Angioedema associated with imiquimod [4]

Journal of the American Academy of Dermatology

Volumn 51, Issue 3, 2004, Pages 477-478

  Barton, James C ^a,b  

^a KAISER PERMANENTE   (United States)

^b 94066 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; IMIQUIMOD; METHYLPREDNISOLONE; MEVINOLIN; PREDNISONE; TERAZOSIN;

ADULT; ANAMNESIS; ANGIONEUROTIC EDEMA; BOWEN DISEASE; CASE REPORT; HOSPITAL DISCHARGE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SKIN ULCER;

EID: 4444378177     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.01.037     Document Type: Article

References (5)

1. Beutner K.R., Spruance S.L., Hougham A.J., Fox T.L., Owens M.L., Douglas J.M. Jr. Treatment of genital warts with an immune response modifier (imiquimod). J Am Acad Dermatol. 38:1998;230-239
2. Persaud A.N., Shamuelova E., Sherer D., Lou W., Singer G., Cervera C., et al. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis. J Am Acad Dermatol. 47:2002;553-556
3. Beutner K.R., Geisse J.K., Helman D., Fox T.L., Ginkel A., Owens M.L. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol. 41:1999;1002-1007
4. Mackenzie-Wood A., Kossard S., de Launey J., Wilkinson B., Owens M.L. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol. 44:2001;462-470
5. Soter N.A. Urticaria and angioedema. Freedberg I.M., Eisen A.Z., Wolff K., Austen K.F., Goldsmith L.A., Katz S.I., et al. Fitzpatrick's Dermatology in general medicine. 5th ed :1999;1409-1419 McGraw-Hill, New York